(Q46798247)
Statements
1 reference
Delayed-release oral mesalamine at 4.8 g/day (800 mg tablet) for the treatment of moderately active ulcerative colitis: the ASCEND II trial (English)
1 reference
William J Sandborn
1 reference
Stephen B Hanauer
1 reference
Asher Kornbluth
1 reference
Seymour Katz
1 reference
Michael Safdi
1 reference
Scott Woogen
1 reference
Gino Regalli
1 reference
Chyon Yeh
1 reference
Nancy Smith-Hall
1 reference
Funmilay Ajayi
1 reference
1 November 2005
1 reference
100
1 reference
11
1 reference
2478-2485
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference